Results 181 to 190 of about 561,995 (314)
Identification of a novel platelet-related prognostic model for hepatocellular carcinoma. [PDF]
Pan H, Cheng X, Dong Y, Li D.
europepmc +1 more source
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober +16 more
wiley +1 more source
Yufeng Yang, Fang Wang, Zeyuan Li, Zhu Wang Department of Gastrointestinal Surgery, First People’s Hospital of Pingjiang, Yueyang, Hunan Province, People’s Republic of ChinaCorrespondence: Zhu Wang, Department of Gastrointestinal Surgery, First People’s ...
Yang Y, Li Z, Wang F, Wang Z
core
Prognostic model for osteoarthritis combining imaging and clinical biomarkers. [PDF]
Yuan L +5 more
europepmc +1 more source
Finding novel vulnerabilities of hypomorphic BRCA1 alleles
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder +10 more
wiley +1 more source
A novel prognostic model for ovarian cancer: construction, validation, and therapeutic insights. [PDF]
Yu T, Gao M, Yu Y, Wang B.
europepmc +1 more source
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi +14 more
wiley +1 more source
Development of a prognostic model for postoperative survival in appendiceal pseudomyxoma peritonei based on clinical indicators. [PDF]
Jiao J +6 more
europepmc +1 more source
MITF maintains genome stability in nonmelanocyte lineages
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir +13 more
wiley +1 more source
Identification and validation of a seven-gene metastasis-associated prognostic model in breast cancer. [PDF]
Yao Y +6 more
europepmc +1 more source

